Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.

Abstract

PURPOSE Widespread prostate specific antigen screening together with the increase in the number of biopsy cores has led to increased prostate cancer incidence. Standard diagnostic tools still cannot unequivocally predict prostate cancer progression, which often results in a significant overtreatment rate. We present recent findings on PCA3 and TMPRSS:ERG… (More)
DOI: 10.1016/j.juro.2011.10.133

Topics

Cite this paper

@article{Salagierski2012MolecularDO, title={Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.}, author={Maciej Salagierski and Jack A Schalken}, journal={The Journal of urology}, year={2012}, volume={187 3}, pages={795-801} }